Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Lung Cancer|Prostate Cancer|Veno-occlusive Disease
Interventions: DRUG: dalteparin|DRUG: standard therapy
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)